vs

Side-by-side financial comparison of HUTCHMED (China) Ltd (HCM) and Smith Douglas Homes Corp. (SDHC). Click either name above to swap in a different company.

HUTCHMED (China) Ltd is the larger business by last-quarter revenue ($270.8M vs $260.4M, roughly 1.0× Smith Douglas Homes Corp.). Smith Douglas Homes Corp. runs the higher net margin — 1.4% vs 0.7%, a 0.6% gap on every dollar of revenue. On growth, Smith Douglas Homes Corp. posted the faster year-over-year revenue change (-9.4% vs -16.5%). Smith Douglas Homes Corp. produced more free cash flow last quarter ($8.7M vs $3.4M).

HUTCHMED (China) Ltd is a biopharmaceutical firm focused on discovering, developing and commercializing targeted and immunotherapies for oncology and immunological diseases. It operates across China and global markets, with multiple marketed oncology drugs and a robust pipeline of late-stage clinical candidates addressing unmet patient needs.

Smith & Wesson Brands, Inc. (S&W) is an American firearm manufacturer headquartered in Maryville, Tennessee, United States.

HCM vs SDHC — Head-to-Head

Bigger by revenue
HCM
HCM
1.0× larger
HCM
$270.8M
$260.4M
SDHC
Growing faster (revenue YoY)
SDHC
SDHC
+7.1% gap
SDHC
-9.4%
-16.5%
HCM
Higher net margin
SDHC
SDHC
0.6% more per $
SDHC
1.4%
0.7%
HCM
More free cash flow
SDHC
SDHC
$5.4M more FCF
SDHC
$8.7M
$3.4M
HCM

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
HCM
HCM
SDHC
SDHC
Revenue
$270.8M
$260.4M
Net Profit
$2.0M
$3.5M
Gross Margin
37.7%
19.9%
Operating Margin
-13.2%
6.5%
Net Margin
0.7%
1.4%
Revenue YoY
-16.5%
-9.4%
Net Profit YoY
-83.6%
-14.3%
EPS (diluted)
$0.00
$0.39

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
HCM
HCM
SDHC
SDHC
Q4 25
$270.8M
$260.4M
Q3 25
$262.0M
Q2 25
$277.7M
$223.9M
Q1 25
$324.5M
$224.7M
Q4 24
$287.5M
Q3 24
$277.8M
Q2 24
$305.7M
$220.9M
Q1 24
$189.2M
Net Profit
HCM
HCM
SDHC
SDHC
Q4 25
$2.0M
$3.5M
Q3 25
$2.1M
Q2 25
$455.0M
$2.4M
Q1 25
$11.9M
$2.7M
Q4 24
$4.1M
Q3 24
$5.3M
Q2 24
$25.8M
$3.6M
Q1 24
$3.0M
Gross Margin
HCM
HCM
SDHC
SDHC
Q4 25
37.7%
19.9%
Q3 25
21.0%
Q2 25
0.1%
23.2%
Q1 25
48.0%
23.8%
Q4 24
25.5%
Q3 24
26.5%
Q2 24
41.1%
26.7%
Q1 24
26.1%
Operating Margin
HCM
HCM
SDHC
SDHC
Q4 25
-13.2%
6.5%
Q3 25
6.6%
Q2 25
-1.3%
7.7%
Q1 25
-5.0%
8.7%
Q4 24
10.4%
Q3 24
14.2%
Q2 24
-9.0%
11.7%
Q1 24
11.3%
Net Margin
HCM
HCM
SDHC
SDHC
Q4 25
0.7%
1.4%
Q3 25
0.8%
Q2 25
163.8%
1.1%
Q1 25
3.7%
1.2%
Q4 24
1.4%
Q3 24
1.9%
Q2 24
8.4%
1.7%
Q1 24
1.6%
EPS (diluted)
HCM
HCM
SDHC
SDHC
Q4 25
$0.00
$0.39
Q3 25
$0.24
Q2 25
$0.52
$0.26
Q1 25
$0.01
$0.30
Q4 24
$0.50
Q3 24
$0.58
Q2 24
$0.03
$0.40
Q1 24
$0.33

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
HCM
HCM
SDHC
SDHC
Cash + ST InvestmentsLiquidity on hand
$1.4B
$12.7M
Total DebtLower is stronger
$93.2M
Stockholders' EquityBook value
$1.2B
$86.7M
Total Assets
$1.8B
$557.6M
Debt / EquityLower = less leverage
0.08×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
HCM
HCM
SDHC
SDHC
Q4 25
$1.4B
$12.7M
Q3 25
$14.8M
Q2 25
$1.4B
$16.8M
Q1 25
$836.1M
$12.7M
Q4 24
$22.4M
Q3 24
$23.7M
Q2 24
$802.5M
$17.3M
Q1 24
$32.8M
Total Debt
HCM
HCM
SDHC
SDHC
Q4 25
$93.2M
Q3 25
Q2 25
$93.4M
Q1 25
$82.8M
Q4 24
Q3 24
Q2 24
$82.1M
Q1 24
Stockholders' Equity
HCM
HCM
SDHC
SDHC
Q4 25
$1.2B
$86.7M
Q3 25
$82.2M
Q2 25
$1.2B
$80.0M
Q1 25
$759.9M
$76.9M
Q4 24
$73.6M
Q3 24
$68.4M
Q2 24
$740.1M
$62.1M
Q1 24
$59.7M
Total Assets
HCM
HCM
SDHC
SDHC
Q4 25
$1.8B
$557.6M
Q3 25
$571.6M
Q2 25
$1.8B
$570.2M
Q1 25
$1.3B
$513.9M
Q4 24
$475.9M
Q3 24
$460.1M
Q2 24
$1.3B
$429.3M
Q1 24
$401.3M
Debt / Equity
HCM
HCM
SDHC
SDHC
Q4 25
0.08×
Q3 25
Q2 25
0.08×
Q1 25
0.11×
Q4 24
Q3 24
Q2 24
0.11×
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
HCM
HCM
SDHC
SDHC
Operating Cash FlowLast quarter
$8.2M
$9.8M
Free Cash FlowOCF − Capex
$3.4M
$8.7M
FCF MarginFCF / Revenue
1.2%
3.4%
Capex IntensityCapex / Revenue
1.8%
0.4%
Cash ConversionOCF / Net Profit
4.21×
2.77×
TTM Free Cash FlowTrailing 4 quarters
$-96.2M
$-36.9M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
HCM
HCM
SDHC
SDHC
Q4 25
$8.2M
$9.8M
Q3 25
$22.8M
Q2 25
$-72.9M
$-28.9M
Q1 25
$40.3M
$-34.9M
Q4 24
$5.5M
Q3 24
$22.9M
Q2 24
$-39.8M
$39.0K
Q1 24
$-9.3M
Free Cash Flow
HCM
HCM
SDHC
SDHC
Q4 25
$3.4M
$8.7M
Q3 25
$21.4M
Q2 25
$-82.2M
$-31.1M
Q1 25
$32.5M
$-35.9M
Q4 24
$4.8M
Q3 24
$22.3M
Q2 24
$-49.9M
$-2.1M
Q1 24
$-9.7M
FCF Margin
HCM
HCM
SDHC
SDHC
Q4 25
1.2%
3.4%
Q3 25
8.2%
Q2 25
-29.6%
-13.9%
Q1 25
10.0%
-16.0%
Q4 24
1.7%
Q3 24
8.0%
Q2 24
-16.3%
-1.0%
Q1 24
-5.1%
Capex Intensity
HCM
HCM
SDHC
SDHC
Q4 25
1.8%
0.4%
Q3 25
0.5%
Q2 25
3.3%
0.9%
Q1 25
2.4%
0.5%
Q4 24
0.2%
Q3 24
0.2%
Q2 24
3.3%
1.0%
Q1 24
0.2%
Cash Conversion
HCM
HCM
SDHC
SDHC
Q4 25
4.21×
2.77×
Q3 25
10.70×
Q2 25
-0.16×
-12.24×
Q1 25
3.38×
-13.01×
Q4 24
1.33×
Q3 24
4.28×
Q2 24
-1.54×
0.01×
Q1 24
-3.12×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

HCM
HCM

Segment breakdown not available.

SDHC
SDHC

Southeast$164.7M63%
Central$95.8M37%

Related Comparisons